X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1539) 1539
index medicus (1070) 1070
female (941) 941
male (884) 884
cancer (803) 803
differentiated thyroid carcinoma (780) 780
middle aged (780) 780
carcinoma (753) 753
differentiated thyroid cancer (749) 749
thyroid neoplasms - pathology (711) 711
thyroid cancer (709) 709
adult (706) 706
oncology (595) 595
aged (558) 558
radiology, nuclear medicine & medical imaging (495) 495
endocrinology & metabolism (465) 465
surgery (449) 449
papillary (436) 436
prognosis (416) 416
thyroid neoplasms - surgery (411) 411
management (388) 388
therapy (348) 348
thyroglobulin (340) 340
thyroidectomy (319) 319
adolescent (311) 311
iodine radioisotopes - therapeutic use (305) 305
metastasis (303) 303
retrospective studies (302) 302
follow-up (298) 298
thyroid (297) 297
medicine & public health (292) 292
diagnosis (265) 265
differentiated thyroid-carcinoma (260) 260
pathology (254) 254
tumors (252) 252
thyroid neoplasms - radiotherapy (246) 246
treatment outcome (239) 239
care and treatment (231) 231
differentiated thyroid-cancer (231) 231
aged, 80 and over (228) 228
radioiodine therapy (221) 221
thyroid neoplasms - diagnosis (221) 221
risk factors (219) 219
radioiodine (209) 209
thyroid neoplasms - diagnostic imaging (204) 204
metastases (199) 199
thyroid neoplasms - therapy (193) 193
research (180) 180
differentiated carcinoma (177) 177
young adult (174) 174
i-131 (171) 171
recurrence (171) 171
carcinoma, papillary - pathology (169) 169
follow-up studies (168) 168
child (167) 167
survival (167) 167
thyroid neoplasms - genetics (162) 162
thyroid neoplasms - mortality (162) 162
thyroglobulin - blood (161) 161
ablation (157) 157
radioactive iodine (155) 155
lymphatic metastasis (152) 152
serum thyroglobulin (151) 151
analysis (149) 149
impact (146) 146
patients (143) 143
neoplasm staging (141) 141
iodine (140) 140
carcinoma, papillary - surgery (138) 138
immunohistochemistry (137) 137
nuclear medicine (135) 135
prognostic-factors (135) 135
health aspects (131) 131
thyroid neoplasms - blood (131) 131
papillary carcinoma (129) 129
thyroid diseases (128) 128
carcinoma - pathology (124) 124
radionuclide imaging (124) 124
risk (124) 124
thyroid carcinoma (121) 121
sensitivity and specificity (120) 120
iodine radioisotopes (119) 119
otorhinolaryngology (117) 117
cell differentiation (116) 116
thyroid neoplasms - metabolism (115) 115
thyroid neoplasms - drug therapy (114) 114
cancer patients (113) 113
expression (113) 113
endocrinology (111) 111
adenocarcinoma, follicular - pathology (107) 107
i-131 therapy (107) 107
medicine (105) 105
papillary thyroid carcinoma (105) 105
mutation (100) 100
radiotherapy (98) 98
survival rate (98) 98
nodules (97) 97
positron-emission-tomography (96) 96
imaging / radiology (95) 95
children (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2632) 2632
German (80) 80
French (79) 79
Spanish (71) 71
Japanese (59) 59
Korean (31) 31
Portuguese (11) 11
Polish (10) 10
Chinese (9) 9
Russian (8) 8
Italian (7) 7
Turkish (7) 7
Czech (3) 3
Arabic (1) 1
Greek (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 12/1998, Volume 83, Issue 12, pp. 2638 - 2648
BACKGROUND The National Cancer Data Base (NCDB) represents a national electronic registry system now capturing nearly 60% of incident cancers in the U. S. In... 
undifferentiated carcinoma | Hürthle cell carcinoma | thyroid carcinoma | National Cancer Data Base | iodine‐131 | papillary carcinoma | follicular carcinoma | anaplastic carcinoma | adjuvant treatment | surgery | Hurthle cell carcinoma | Anaplastic carcinoma | Papillary carcinoma | Surgery | Adjuvant treatment | Undifferentiated carcinoma | Follicular carcinoma | Iodine-131 | Thyroid carcinoma | MANAGEMENT | MEDULLARY CARCINOMA | DIFFERENTIATED CARCINOMA | iodine-131 | SURGICAL-TREATMENT | ONCOLOGY | PAPILLARY | GLAND | Carcinoma, Medullary - epidemiology | United States - epidemiology | Adenocarcinoma - pathology | Adenocarcinoma, Follicular - pathology | Humans | Middle Aged | Thyroid Neoplasms - epidemiology | Carcinoma - mortality | Child, Preschool | Adenocarcinoma, Follicular - mortality | Infant | Registries - statistics & numerical data | Carcinoma - epidemiology | Carcinoma, Papillary - epidemiology | Aged, 80 and over | Adult | Databases as Topic - statistics & numerical data | Carcinoma - pathology | Child | Infant, Newborn | Thyroid Neoplasms - mortality | Carcinoma, Medullary - mortality | Adenocarcinoma, Follicular - epidemiology | Carcinoma, Medullary - pathology | Survival Rate | Carcinoma, Papillary - pathology | Carcinoma, Papillary - mortality | Adolescent | Aged | Adenocarcinoma - epidemiology | Neoplasm Staging | Adenocarcinoma - mortality | Cohort Studies | Thyroid Neoplasms - pathology | Statistics | Thyroid cancer | Registries (in medicine)
Journal Article
Human Pathology, ISSN 0046-8177, 2017, Volume 65, pp. 133 - 139
Summary Metastatic papillary thyroid carcinoma without an identifiable primary tumor despite extensive microscopic examination of the thyroid gland is a rare... 
Pathology | Lymph node metastasis | Occult primary thyroid carcinoma | Poorly differentiated thyroid carcinoma | BRAF | Papillary thyroid carcinoma | Anaplastic thyroid carcinoma | METAANALYSIS | MICROCARCINOMA | PATHOLOGY | SPONTANEOUS REGRESSION | FEATURES | MELANOMA | FOLLICULAR VARIANT | MUTATIONS | SPECTRUM | PROGRESSION | Immunohistochemistry | Humans | Middle Aged | Male | Thyroid Neoplasms - therapy | Neoplasm Grading | DNA Mutational Analysis | Adult | Female | Thyroid Carcinoma, Anaplastic - therapy | Cell Differentiation | Retrospective Studies | Carcinoma - secondary | Genetic Predisposition to Disease | Neoplasms, Unknown Primary - genetics | Thyroid Carcinoma, Anaplastic - secondary | Thyroid Carcinoma, Anaplastic - genetics | Lymphatic Metastasis | Thyroid Cancer, Papillary | Thyroid Neoplasms - genetics | Phenotype | Carcinoma, Papillary | Proto-Oncogene Proteins B-raf - genetics | Neoplasms, Unknown Primary - therapy | Carcinoma - genetics | Carcinoma - therapy | Aged | Biomarkers, Tumor - genetics | Mutation | Neoplasms, Unknown Primary - pathology | Thyroid Neoplasms - pathology | Thyroid gland | Carcinoma | Metastasis | Thyroid diseases | Cancer | Lymphatic system | Thyroid cancer | Medical prognosis | Melanoma | Patients | Iodine | Tumors | occult primary thyroid carcinoma | lymph node metastasis
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2015, Volume 136, Issue 5, pp. 1218 - 1227
Journal Article
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 02/2018, Volume 88, Issue 2, pp. 295 - 302
Summary Objective A highly sensitive thyroglobulin assay (Elecsys® Tg II, Roche Diagnostics, Penzberg, Germany) has become available for monitoring patients... 
highly sensitive | differentiated thyroid carcinoma | thyroglobulin | immunoassay | CANCER PATIENTS | GUIDELINES | FOLLOW-UP | RISK | SERUM | THYROTROPIN | STAGING SYSTEM | STIMULATED THYROGLOBULIN | THERAPY | ENDOCRINOLOGY & METABOLISM | LIFE EXPECTANCY | Medicine, Experimental | Medical research | Thyroid cancer | Carcinoma | Cancer | Thyroglobulin | Thyroid carcinoma | Thyroid
Journal Article
Journal Article